Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma

Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinomas (PDAC) represent one of the deadliest cancers worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments.

Bibliographic Details
Main Authors: Daniel C. Osei-Bordom, Gagandeep Sachdeva, Niki Christou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
pancreatic ductal adenocarcinoma
liquid biopsy
exosomes
prognosis
personalized treatment
circulating free DNA (cfDNA)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.788869/full

Similar Items

Similar Items